Filing Details

Accession Number:
0001127602-12-014144
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-04-18 16:29:57
Reporting Period:
2012-04-17
Filing Date:
2012-04-18
Accepted Time:
2012-04-18 15:29:57
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
816956 Conmed Corp CNMD Electromedical & Electrotherapeutic Apparatus (3845) 160977505
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1222114 J Joseph Corasanti 101 Winship Road
New Hartford NY 13413
President & Ceo No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2012-04-17 15,000 $17.74 92,161 No 4 M Direct
Common Stock Disposition 2012-04-17 15,000 $29.32 77,161 No 4 S Direct
Common Stock Acquisiton 2012-04-18 923 $17.74 78,084 No 4 M Direct
Common Stock Disposition 2012-04-18 923 $29.30 77,161 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Options To Purchase Common Stock Disposition 2012-04-17 15,000 $0.00 15,000 $17.74
Common Stock Options To Purchase Common Stock Disposition 2012-04-18 923 $0.00 923 $17.74
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
923 2013-05-20 No 4 M Direct
0 2013-05-20 No 4 M Direct
Footnotes
  1. 5 year vesting schedule, 20% vest each year starting 5/20/2004.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $29.30 to $29.33. Full information regarding the number of shares sold at each separate price will be provided upon request of the commission staff, ConMed, or a ConMed security holder.
  3. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 15, 2012.